MR [Mindray Medical International] SC 13G/A: (Original Filing)

[1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Baillie Gifford & Co (Scottish partnership) _______________________________________________________________________ 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a).................................................................... (b).................................................................... _______________________________________________________________________ 3. SEC Use Only _______________________________________________________________________ 4. Citizenship or Place of Organization SCOTLAND UK _______________________________________________________________________ Number of 5. Sole Voting Power 7493695 Shares Bene ______________________________________________________]

MR [Mindray Medical International] SC 13G/A: 1. Names of Reporting Persons. I.R.S. Identification Nos.

[1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Baillie Gifford & Co (Scottish partnership) _______________________________________________________________________ 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a).................................................................... (b).................................................................... _______________________________________________________________________ 3. SEC Use Only _______________________________________________________________________ 4. Citizenship or Place of Organization SCOTLAND UK _______________________________________________________________________ Number of 5. Sole Voting Power 7493695 Shares Bene ______________________________________________________]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Preliminary 2014 Operating Results and 2015 Net Revenues Guidance SHENZHEN, China, Jan. 12, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray," NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2014. The company also provided net revenues guidance for 2015. For the] []

MR [Mindray Medical International] 6-K: Mindray Announces Preliminary 2014 Operating Results and 2015

[Mindray Announces Preliminary 2014 Operating Results and 2015 Net Revenues Guidance SHENZHEN, China, Jan. 12, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray," NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2014. The company also provided net revenues guidance for 2015. For the] []

By | 2016-03-29T00:35:10+00:00 January 12th, 2015|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[MINDRAY MEDICAL INTERNATIONAL LIMITED NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 10, 2014 On December 10, 2014, Mindray Medical International Limited, a Cayman Islands company (the “Company”), will hold its annual general meeting of shareholders at the Company’s offices at the Company’s Hong Kong office at FLAT/RM 15-16 BLK 1 11/F, Grand Century, 193 Prince] [MINDRAY MEDICAL INTERNATIONAL LIMITED PROXY STATEMENT General The board of directors of Mindray Medical International Limited (the “Company”) is soliciting proxies for the annual general meeting of shareholders to be held on December 10, 2014 at 11:00 a.m., local time, or at any adjournment or postponement thereof. The annual general meeting will be held at the Company’s Hong Kong office] [] []

By | 2016-03-29T00:39:02+00:00 November 13th, 2014|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[Shenzhen, China – November 3, 2014 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2014. Highlights for Third Quarter 2014 - Net revenues increased 9.6% year-over-year to $324.6 million. China sales grew 17.9% year-over-year, representing 48.0% of] []

MR [Mindray Medical International] 6-K: Shenzhen, China – November 3, 2014 – Mindray

[Shenzhen, China – November 3, 2014 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2014. Highlights for Third Quarter 2014 - Net revenues increased 9.6% year-over-year to $324.6 million. China sales grew 17.9% year-over-year, representing 48.0% of] []

By | 2016-03-29T00:42:52+00:00 November 3rd, 2014|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2014 Financial Results Shenzhen, China – August 11, 2014 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2014. Highlights for Second Quarter 2014 - Net revenues increased 8.9% year-over-year to $334.5 million. International] []

Skip to toolbar